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complicated set-up for the tests.5-7 Almost all of these
studies investigate lung function after a fixed preserva-
tion time. No systematic or ultrastructural studies have
been performed in these comparisons. The living rat
lung model developed in our laboratory allows an iso-
lated lung to undergo perfusion for 3 to 4 hours. This
model has provided a simple and stable set-up for iso-
lated lung function studies. In this study we compared
two common intracellular preservation solutions
(University of Wisconsin [UW] and Euro-Collins [EC]
solutions) with an extracellular preservation solution
(low-potassium dextran [LPD] solution) for hypother-
mic lung preservation. A common extracellular perfu-
sion solution (Krebs-Henseleit [KH] solution) was also
used for comparison with the above solutions.
Material and methods
Healthy, adult, Sprague-Dawley rats weighing 250 to 300 g
were used for this study. All animals received humane care in
compliance with the “Principles of Laboratory Animal Care”
D espite more than 30 years of extensive study, lungpreservation time is still very short.1 The reported
effects of currently used solutions for lung preservation
vary substantially. This is partly related to the difficul-
ties in lung function tests after preservation. Most
experiments only test lung function in a very short time
period, such as 10 to 20 minutes.2-4 Other studies use a
Objective: We sought to test the effectiveness of 4 different solutions for
hypothermic rat lung preservation. 
Methods: One hundred ninety-two rats were used. The rats were divided into
4 groups, and University of Wisconsin, Euro-Collins, low-potassium dex-
tran, or Krebs-Henseleit solution was used in each group. They were further
divided into 6 subgroups of 8 rats each. The lungs were preserved at 4°C for
0, 4, 6, 8, 12, or 24 hours, respectively, and lung function was studied by
using a living rat perfusion model. 
Results: Pulmonary arterial flow decreased in each group after 4 to 6 hours of
preservation; the low-potassium dextran group decreased the least and the
Krebs-Henseleit group decreased the most. Pulmonary vascular resistance
increased in each group after 6 hours of preservation; the Krebs-Henseleit
group increased the most. Although airway pressure increased, static lung com-
pliance and gas exchange capacity decreased after 8 hours of preservation; the
Krebs-Henseleit group exhibited the worst values. Lung tissue wet/dry weight
ratio increased gradually during preservation; the University of Wisconsin
group exhibited the least increase. An ultrastructural study indicated the least
morphologic changes in the low-potassium dextran group at 24 hours. 
Conclusions: At 4°C, all solutions preserved rat lungs for 4 hours with
acceptable function. However, 6 hours of preservation resulted in damaged
pulmonary function in some lungs, and this damage increased when preser-
vation time was extended. The lungs preserved in low-potassium dextran
solution had the best overall function, but the lungs preserved in University
of Wisconsin solution had less edema. (J Thorac Cardiovasc Surg
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formulated by the National Society for Medical Research and
the “Guide for the Care and Use of Laboratory Animals” pre-
pared by the Institute of Laboratory Animal Resources and
published by the National Institutes of Health (National
Institutes of Health publication No. 86-23, revised 1985).
Solutions used. UW and EC solutions were purchased
commercially. LPD and KH solutions were made in our lab-
oratory. The compositions of these solutions are shown in
Table I.
Perfusion apparatus. The lung function study was per-
formed as previously described.8 Briefly, the isolated lung
was suspended in a perfusion chamber. The cap of the perfu-
sion chamber was removable and had a tube for attaching the
trachea of the isolated lung. This tube was connected to a
rodent respirator (model 683; Harvard Apparatus Co, Inc, S
Natick, Mass) for ventilation. On the top of the tube, a Y con-
nector was attached to a Gould pressure transducer (Gould
Instrument Systems, Inc, Valley View, Ohio) for measuring
respiratory pressure. The cap had another tube connected to
the jugular vein of the host rat for perfusion of the pulmonary
artery of the isolated lung. A 2-mm flow probe was incorpo-
rated into this line and was interfaced with a Transonic T 201
flowmeter (Transonic Systems, Inc, Ithaca, NY) for monitor-
ing the perfusion flow. Venous blood return from the isolated
lung was collected at the bottom of the perfusion chamber
and was returned to the left carotid artery of the host rat by
using a Minipols roller pump (model 312; Gilson Co,
Middleton, Wis). The chamber was heated by a temperature-
controlled water bath with a circulating pump maintained at
37°C (Fig 1).
Preparation of the host rat. Anesthesia was induced by
means of an intraperitoneal injection of sodium pentobarbital
(35-50 mg/kg body weight). The cervical trachea was cannu-
lated. The rats’ lungs were ventilated through an endotracheal
tube by using a rodent respirator with room air. The tidal vol-
ume was 2.5 to 3.5 mL, and the rate was 40 to 50 cycles/min.
A 2-mm catheter was inserted into the right jugular vein.
Heparin sodium (3 mg/kg) was infused intravenously, and
both carotid arteries were cannulated with 0.5-mm catheters.
The catheter in the right carotid artery was connected to a
Gould pressure transducer for blood pressure monitoring.
From the right jugular vein of the host rat, the blood with-
drawn by gravity flowed to the perfusion chamber to perfuse
the pulmonary artery of the isolated lung. A hydrostatic pres-
sure of 25 mm Hg was maintained by adjusting the height
distance between the host rat and the isolated lung. Blood
returned from the pulmonary vein of the isolated lung was
collected and recirculated, as described earlier. Arterial blood
samples were taken from the host rat every 10 minutes for
blood gas and electrolyte analysis. The blood return rate, tidal
volume, and respiratory rate for the host rat were adjusted to
maintain stable arterial blood pressure and arterial blood gas
values.
Preparation and preservation of the isolated lung. The
lung donor rats were anesthetized by using an intraperitoneal
injection of sodium pentobarbital (35-50 mg/kg body
weight). The cervical trachea was cannulated, and each ani-
mal was ventilated by using a rodent respirator with room air.
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Table I. Composition of preservation solutions
UW EC LPD KH
Potassium 125 115 4 5.25
Sodium 30 10 168 150
Calcium — — — 2
Magnesium 5 — — 1.2
Chloride — 15 103 131
Phosphate 25 57.5 36.7 1.25
Sulfate 5 — — 1.2
Glucose — 196 — 10
Glutathione 3 — — —
Dextran 40 — — 1.25 —
Adenosine 5 — — —
Lactobionate 100 — — —
Raffinose 30 — — —
Allopurinol 1 — — —
Dexamethasone 20.3 — — —
Hydroxyethyl starch (g/dL) 5 — — —
Insulin (U/L) 40 — — —
Osmolality (mOsm/L) 320 375 285 312
Concentrations are expressed as millimoles per liter, except where noted.
Fig 1. Living rat perfusion apparatus. The isolated lung is
perfused by the blood from the internal jugular vein of the
host rat. Blood returned from the isolated lung is collected in
the perfusion chamber (C) and reservoir (R) and then returned
to the arterial system of the host rat by means of a roller
pump. The open arrow indicates the direction of flow of
nonoxygenated venous blood. The filled arrows indicate the
direction of flow of oxygenated blood. (From Wu G, Zhang
F, Salley RK, Diana JN, Su T-P, Chien S. Delta opioid
extends hypothermic preservation time of the lung. J Thorac
Cardiovasc Surg 1996;111:259-67.)
A tidal volume of 2.5 to 3.5 mL and a rate of 40 to 50
cycles/min were maintained. An incision was made below the
xiphoid process, and the retrosternal space was exposed by
means of blunt dissection. Two large straight clamps were
attached to the incision to open the chest by means of medi-
an sternotomy, avoiding injury to the lungs or great vessels.
After intravenous administration of heparin sodium (3
mg/kg), the inferior pulmonary ligaments were carefully
divided. The left superior vena cava was then dissected, li-
gated, and divided. The hilum of the left lung was approached
anteriorly, and the vessels and bronchus were separated by
using blunt dissection. The left pulmonary artery was dis-
sected, and a suture was placed loosely around it. The main
pulmonary artery was then transected through the transverse
sinus to allow placement of a cannula in the left pulmonary
artery. The loose suture around the left pulmonary artery was
tied, and preservation solution was then infused through the
cannulated left pulmonary artery. In this study one of the 4
preservation solutions (10-15 mL at 4°C) was flushed
through the lung through the pulmonary artery at a gravity
gradient of 25 cm H2O. The left atrium was partially excised
for decompression. After being flushed, the lungs were
removed and immersed in the preservation solutions before
performing function studies. The trachea was clamped at the
end of inspiration to maintain inflation (with room air) during
the hypothermic storage. 
Animal groups studied. One hundred ninety-two rats
were used in this study. The animals were randomly divided
into 4 main groups, with 48 rats per group. UW, EC, LPD, or
KH solution was used in each group, and the animals were
further randomly divided into 6 subgroups of 8 rats each
according to preservation time. Group 1 was not subjected to
hypothermic storage and was used as the normal control
group. In this group the left lung was immediately transferred
to the perfusion chamber for function studies. In the remain-
ing 5 groups, the lungs were preserved for 4 hours (group 2),
6 hours (group 3), 8 hours (group 4), 12 hours (group 5), and
24 hours (group 6). During the perfusion period, the isolated
lung was ventilated with room air at a respiratory rate of 40
to 50 cycles/min, a tidal volume of 2.5 to 3.5 mL, and a pos-
itive end-expiratory pressure of 0.5 cm H2O.
Procedure for lung function studies. After connecting to
the perfusion apparatus, a period of 5 to 10 minutes was
needed for equilibration. Pulmonary arterial blood flow, pul-
monary perfusion pressure, and airway pressure (AWP) were
recorded continuously on a Gould strip chart recorder. The
lungs were constantly inspected for edema, hemorrhage, or
atelectasis. Blood samples were taken from the pulmonary
artery and pulmonary vein every 10 minutes for blood gas
analyses with a Nova State Profile 5 blood gas analyzer
(Nova Biomedical, Waltham, Mass). From these parameters,
pulmonary vascular resistance (PVR), airway resistance, sta-
tic lung compliance, and pulmonary vein oxygen gain were
calculated.
At the end of the experiment, lung tissue samples were
taken for histologic and wet/dry weight ratio studies. For lung
tissue wet-to-dry weight measurements, the samples were
blotted to remove excess water, and their wet weights were
recorded. The samples were then placed in the 80°C oven for
3 days before dry weights were obtained.
Histologic study. Tissue samples were obtained from the
upper lobes of the lungs. Each sample was then immersion
fixed overnight at 4°C in 10% buffered formalin solution con-
taining 1% glutaraldehyde. Four to six 1-mm cubes were cut
with a sharp blade from each lung sample, postfixed in 1%
osmium tetroxide, dehydrated in ascending concentrations of
ethanol, and embedded in Araldite 502 fixative. After poly-
merization, 1-µm thick sections were cut and stained with
toluidine blue for light microscopic viewing. Thin sections
were stained with uranyl acetate and lead citrate before being
examined with a Philips 201C electron microscope.
Statistical analysis. Data were collected every 10 minutes
during the perfusion period from 0 to 60 minutes. In each
subgroup of 8 lungs, there were 56 values for each variable.
These data points were collected and managed by using a
commercial spreadsheet software package (Lotus 123 for
Windows, version 1.0) yielding the mean, SD, and SEM for
each group at each preservation time period. A commercial
statistics software package (SigmaStat, version 1.01, SPSS,
Inc, Chicago, Ill) was used for data analysis. The data were
first evaluated by using analysis of variance for repeated mea-
sures. Significant effects were further examined by using the
Dunnett procedure to compare all groups. All data were
expressed as mean values ± SEM.
Results
Pulmonary perfusion flow and PVR. Normal pul-
monary perfusion flow ranged from 1.88 ± 0.28 to 2.89
± 0.29 mL/min (mean, 2.59 ± 0.11 mL/min). After 4
hours of preservation, flow decreased slightly in all
groups except the LPD group. After 6 hours of preser-
vation, flow was diminished further in each group,
including the LPD group, with a continuous decline
after 8 hours of preservation in the EC and KH groups.
Flow in these two groups decreased to less than 1
mL/min after 12 and 24 hours of preservation.
However, in the UW and LPD groups, the decrease in
flow was not that severe (ie, less flow than the 4-hour
and 6-hour groups but higher flow than the EC and KH
groups; P = .001). Overall, the LPD group maintained
the best flow (Fig 2).
Normal PVR ranged from 9.28 ± 0.70 to 17.15 ± 3.45
mm Hg · mL–1 · min–1 (mean, 9.67 ± 0.26 mm Hg ·
mL–1 · min–1). PVR increased slightly at 4 hours, but
this increase was only statistically significant in the KH
group, in which it increased to 16.29 ± 0.21 mm Hg ·
mL–1 · min–1 (P = .02 compared with 0 hours). PVR
increased significantly after 8 to 12 hours of preserva-
tion. This increase was especially significant in the EC
and KH groups but less severe in the LPD group at
almost all time periods (Fig 3).
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Maximum AWP and static lung compliance.
Maximum AWP in the normal control animals ranged
from 7.50 ± 0.59 to 10.13 ± 1.19 mm Hg (mean, 8.55
± 0.34 mm Hg). Maximum AWP increased significant-
ly after 4 hours of preservation, especially in the UW
and KH groups, in which it almost doubled (P = .005
compared with 0 hours) and continued to increase. The
LPD group had the smallest increase in AWP during all
time periods, except at 24 hours (Fig 4). Maximum air-
way resistance exhibited similar changes.
Static lung compliance in the normal control animals
ranged from 0.22 ± 0.02 to 0.28 ± 0.02 mL/mm Hg
(mean, 0.25 ± 0.01 mL/mm Hg) and decreased gradu-
ally during the preservation period. This decrease was
most significant in the UW and KH groups at 4 and 6
hours (P = .02 compared with 0 hours). After that, the
decrease was not as significant. In the LPD group the
decrease in static lung compliance was much slower.
The decrease in the EC group stayed between these two
extremes (Fig 5).
Oxygen exchange capacity. Pulmonary venous oxy-
gen gain in the normal control animals ranged from 78
± 15 to 132 ± 15 mm Hg (mean, 121 ± 6 mm Hg).
Oxygen gain decreased sharply in the UW and KH
groups after 4 hours of preservation. In the EC and
LPD groups it was maintained at almost normal levels.
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Fig 2. Comparison of pulmonary blood flow in isolated rat lungs.
Fig 3. Comparison of PVR in the 4 groups during perfusion.
However, it decreased in all groups after 6 hours of
preservation (P = .005 compared with normal levels). It
decreased further after 8 to 12 hours of preservation,
but the decrease was not as sharp as that seen at the
beginning. All groups showed very low oxygen gain at
24 hours of preservation (Fig 6).
Lung tissue wet/dry weight ratio. Average normal
lung tissue wet/dry weight ratio was 6.23 ± 0.33. It
increased gradually during the preservation period in
all groups except the UW group. The increase was most
dramatic in the KH group. The UW group maintained
a low ratio. Even after 24 hours, it was only slightly
higher than normal (Fig 7).
Electron microscope study. The normal control ani-
mals taken at 0 hours showed a typical lung parenchy-
ma with numerous clusters of alveoli. The interalveolar
wall was lined by flattened type I pneumocytes and a
few bulging type II pneumocytes on the respiratory sur-
face. The vascular surface was continuously paved by
thin-walled endothelial cells. The interstitium con-
tained either a single fused or two distinct basal lami-
nae, some reticular fibrils, and occasionally fibroblast-
like cells. The perfusion process removed most of the
erythrocytes, but a few adhering leukocytes and alveo-
lar macrophages remained (Fig 8). Early ultrastructur-
al changes appeared similar among these groups. In the
4- and 6-hour samples taken from the EC or UW
groups, little cytologic change was observed. Signs of
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Fig 4. Comparison of maximum AWP of the isolated lungs in the 4 groups.
Fig 5. Comparison of static lung compliance in the 4 groups.
deterioration, such as the increased heterochromatin
formation in pneumocytes and endothelial cells,
became common by 12 hours of hypothermic preserva-
tion (Fig 9). Although the tissue remained intact, by 24
hours the majority of the cells showed some degree of
mitochondrial swelling and vesiculation of the rough
endoplasmic reticula. Many nuclei contained highly
compacted chromatin. The endothelial cells continued
to exhibit hyperchromatic cytoplasm, with a plethora of
microvilli formation (Fig 10). However, samples from
the lungs preserved with LPD solution appeared slight-
ly better. The endothelial lining showed small bleb for-
mation but no other changes. The intact type II pneu-
mocyte contained lamellar bodies, a few vesiculated
rough endoplasmic reticulum, and intact mitochondria
(Fig 11). The worst samples were seen from the lungs
preserved with KH solution. Changes were observed in
both the pneumocyte and the endothelium. In the for-
mer, heterochromatin often predominated and the mito-
chondria appeared more compact and darkly stained.
Hyperchromatic nuclei and the darkly stained cyto-
plasm were associated with the endothelium (Fig 12).
Although no quantitative electron microscopy was per-
formed, the inferior tissue preservation in the last group
was distinctive even at light microscopy level.
Ultrastructural changes in both the EC and UW groups
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Fig 6. Comparison of pulmonary venous oxygen gains in the 4 groups during perfusion.
Fig 7. Comparison of lung tissue wet/dry weight ratios after preservation and perfusion.
appeared similar at 24 hours, and changes in these two
groups were somewhere between those found in the
KH and LPD groups.
Pattern of functional recovery during reperfusion.
At the beginning of reperfusion, lung function
appeared to be similar among different subgroups. This
is especially true for the first 10 to 20 minutes of reper-
fusion, when all the lines tend to be very close. Only
after 20 to 30 minutes of perfusion did they show more
differences. One example is airway resistance (Fig 13),
in which more differences were shown after 30 minutes
of reperfusion. 
Discussion
Among the 4 solutions used in this study, LPD
appeared to have the best overall protection to lung
function, with higher pulmonary arterial flow and stat-
ic lung compliance and lower PVR and AWP. However,
UW solution appears to be the most effective in pre-
venting tissue edema. This has been attributed to more
impermeant contents in UW solution. The benefit of
these agents in suppressing cell swelling has been
shown not only in lung-preservation solutions but also
in other organ-preservation solutions.9,10 Unfortu-
nately, less tissue edema does not necessarily translate
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Fig 8. A portion of normal control lung tissue showing the
presence of a type II pneumocyte with a lamellar body
(arrows) and a few scattered mitochondria (M). The associat-
ed capillary (C) is lined by a thin rim of endothelium with a
patent lumen (original magnification 28,000×).
Fig 9. A well-preserved type II pneumocyte in a lung pre-
served in a 12-hour UW solution is contrasted by darkly
stained endothelial cells with microvilli projections (arrow-
heads; original magnification 9000×). C, Capillary; M, mito-
chondria.
Fig 10. A section taken from a 24-hour EC solution–pre-
served lung showing a type II pneumocyte with swollen mito-
chondria (M) and vesicle formation (V). The endothelial sur-
face is lined by a plethora of microvilli (arrows; original
magnification 28,000×).
Fig 11. A section of rat lung preserved for 24 hours with LPD
solution. Except for the nuclear chromatin becoming more
condensed, the lung parenchyma appeared intact and within
normal range. Note the presence of a type II pneumocyte with
a darkly stained nucleus (original magnification 8500×).
into better function directly. UW solution caused high-
er AWP and lower compliance. One contributing factor
may be that the higher potassium concentrations in UW
solution may cause vascular endothelial damage11 and
pulmonary vasoconstriction, resulting in an uneven dis-
tribution.2,9 Impaired flow in the microcirculation after
reperfusion is a potential problem after lung transplan-
tation.12 The higher viscosity in UW solution makes
this situation worse. The use of modified low-potassi-
um UW or EC solutions (potassium concentration of
only 4-20 mmol/L) for lung preservation has been
reported to improve results.4,13 The use of pulmonary
vasodilators, such as epoprostenol (prostacyclin;
prostaglandin I2) and alprostadil (prostaglandin), has
also been reported to effectively extend preservation of
the lung.14 Such intervention was not used in this study
to allow the direct comparison of flush solutions, and
the use of these vasodilators is not universally accept-
ed.15-17 It is interesting to note that both UW and EC
solutions had a similar effect, but EC solution tended to
have a more uniform protection than UW solution in
short-term preservation (4-6 hours). Only after 8 hours
did UW solution show better function than EC solution,
as indicated by pulmonary arterial flow, PVR, AWP,
and oxygen exchange capacity. This finding is in agree-
ment with those of other studies. In a study reported by
Bresticker and colleagues,5 EC solution showed worse
lung function than UW solution after 17 hours of
preservation. In cultured pulmonary endothelial cells,
Hall and colleagues18 found that EC solution provided
a faster structural and functional recovery than UW
solution. However, Carbognani and colleagues19 did
not find any significant difference between these two
solutions at 6 hours of preservation. Our results may
provide some clue to many conflicting reports. It
appears that there is a switch time during which these
two solutions provide similar results, and this time is
around 6 to 8 hours.
In contrast to the UW and EC solutions, flushing
with LPD solution produced very little increase in PVR
and an insignificant decrease in pulmonary arterial
flow within 4 to 6 hours. During reperfusion, pul-
monary arterial flow and pulmonary vein oxygen gain
were higher, and PVR and AWP were lower in lungs
flushed with LPD solution. The beneficial effect of
LPD solution has been reported in lung preserva-
tion20-23 and in cell or tissue cultures.24,25 Although the
exact mechanism is still not clear, several beneficial
effects of dextran have been proposed. These include
improving microvascular flow under various condi-
tions26; coating the surface of red blood cells, resulting
in disaggregation; and increasing the deformability of
red blood cells.27 Further benefit may be gained from
the added antithrombotic effect resulting from the sur-
face coating of platelets and endothelial cells28 and
reduced lipid peroxidation.29 Dextran is impermeable
to cell membranes and may counteract the obligatory
cell swelling caused by anoxic hypothermic storage.22
Although we do not know which property is the most
important, it appears that a combined role of these
effects is important.
Our results also indicate that a short perfusion time
may not correctly reflect lung function because during
the first 10 to 20 minutes of perfusion, all the lines tend
to be very close. This phenomenon was also shown in
some previous studies, such as those by Hausen,23
Xiong,30 Hopkinson,31 Bresticker,5 and their col-
leagues. We still do not know the exact mechanism for
this phenomenon, but caution must be taken when a
very short perfusion time is used for lung function
tests.
Although a complete detailed comparison is beyond
the scope of this article, ultrastructural findings indi-
cate that regardless of the solutions used, there is a
gradual morphologic deterioration with preservation
time. The differences among the 4 groups are very
slight at earlier stages (4-8 hours) and are better shown
at later stages. Although there is a clear morphologic
advantage with the use of UW, EC, or LPD solutions
over KH solution, the combined morphologic data and
the physiologic records would favor the use of LPD
solution.
Although KH solution has low potassium concentra-
tion like LPD, its protective effect is clearly least
among the 4 solutions tested. This fact shows that
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Fig 12. Nuclear chromatin condensation in a type II pneumo-
cyte and the adjacent endothelial cells (E) indicate a relative-
ly poor tissue preservation with KH solution alone for 24
hours (original magnification 13,000×).
extensive research work in the past 3 decades has pro-
duced some encouraging results. It also proves that fur-
ther refinement of the pulmonary preservation solu-
tions that provide better function and morphologic
protection is possible.
Although this study has provided the most complete
time-related results combined with ultrastructural stud-
ies, there are still several limitations.
First, because small animals have a much higher meta-
bolic rate32 and rodent lungs have a higher sensitivity to
potassium concentrations, extrapolation to larger ani-
mals or human subjects may be more difficult. This may
explain some of the differences between the findings of
our study and those of some other studies.33,34
Second, in clinical practice many centers use pul-
monary vasodilators, such as prostacyclin or prosta-
glandins. This may compensate for some of the adverse
effects caused by higher potassium in UW and EC
solutions, therefore altering the final results.
Third, unlike the heart, liver, and kidney, the best
preservation temperature for the lungs may not be at
0°C to 4°C.35 This is another issue that needs further
study.
Nevertheless, the results showed consistent changes
of lung function with hypothermic preservation time,
indicating a very stable model for isolated lung func-
tion tests. The results provide a useful guideline for
improving solutions for maximum lung preservation.
In conclusion, rat lung function is impaired gradual-
ly during hypothermic preservation at 4°C. However,
many lungs still maintain good function after 6 hours
of preservation. When the preservation time exceeds 12
hours, lung function is severely impaired. It appears
that LPD solution provides the best overall protection
among the 4 solutions tested. In short-term (4-6 hours)
hypothermic preservation, LPD and EC solutions pro-
vide more uniform protection than UW solution.
However, lungs preserved by UW solution had the least
tissue edema.
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